Phase2a Nerofe study has begun in Rabin and Kaplan medical centers

PHASE 1B/2A Clinical trial started

Cooperation with Harvard Medical School (MGH)

ISK has signed an agreement for cooperation with Harvard Medical School for drug development to treat neurodegenerative diseases

Prof. Marc E. Lippman – Famous breast cancer expert (KOL ) has joined ISK Ltd

Marc E. Lippman, MD, MACP FRCP is the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Leonard School of Medicine, and was Chairman of the Department of Medicine from May 2007 to May 2012. He is currently Deputy Director of the Sylvester Comprehensive Cancer Center. Previously Dr. Lippman was the John […]

ISK attended the 2019 Sachs conference in Zurich

Prof. Rosenblatt, Joseph D, M.D, a KOL in hematology, has joined ISK’s advisory board